MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1111/dom.70092

Медицинская библиотека · Diabetes, obesity & metabolism · 2025

The protective role of TIGIT+ B cells in attenuating type 1 diabetes progression.

Peng Yiman, Li Jingyue, Deng Ying, Zhou Zhiguang, Shu Mengyao

СтатьяПеревод в очереди

Аннотация

AIMS: Type 1 diabetes (T1D) is an autoimmune disease caused by the destruction of insulin-producing pancreatic β-cells. While T cells are well-known critical, growing evidence shows that B cells also play a key role in T1D development. T cell immunoreceptor with immunoglobulin and ITIM domain (TIGIT), as an inhibitory immune checkpoint, is important in maintaining immune homeostasis and has become a therapeutic target for several autoimmune diseases. Our recent study identified a protective role of TIGIT+ regulatory T cells (Tregs) in T1D. However, the involvement of TIGIT+ B cells in T1D progression remains unclear.

MATERIALS AND

METHODS

This study investigated the expression, functional and metabolic characteristics of TIGIT+ B cells in T1D patients and non-obese diabetic (NOD) mice using flow cytometry. The regulatory mechanisms were further elucidated through T cell-B cell co-culture experiments. Additionally, in vivo intervention studies were conducted to explore potential therapeutic targets for T1D.

RESULTS

We found that the frequency of TIGIT+ B cells was decreased and negatively correlated with disease progression in T1D. TIGIT+ B cells showed decreased co-stimulation, activation, proliferation, pro-inflammatory cytokine production, glucose metabolism and increased anti-inflammatory cytokine production compared to TIGIT- B cells. Furthermore, in vitro co-culture experiments revealed that TIGIT+ B cells suppressed the pro-inflammatory differentiation and pathogenic functions of T cells. Importantly, the use of TIGIT-immunoglobulin or adoptive transfer of TIGIT+ B cells both effectively prevented the disease onset and hyperglycaemia in cyclophosphamide-accelerated NOD mice.

CONCLUSIONS

Our study provides a theoretical basis for targeting TIGIT+ B cells as a novel immunotherapy strategy for T1D.

Для цитирования: Peng Yiman, Li Jingyue, Deng Ying, Zhou Zhiguang, Shu Mengyao. The protective role of TIGIT+ B cells in attenuating type 1 diabetes progression.. Diabetes, obesity & metabolism. 2025. DOI: 10.1111/dom.70092.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.